Down-regulation of natural killer cells and of γ/δ T cells in systemic lupus erythematosus. Does it correlate to autoimmunity and to laboratory indices of disease activity?

Lupus

Volumn 9, Issue 5, 2000, Pages 333-337

  Riccieri, V ^a,b   Spadaro, A ^a   Parisi, G ^a   Taccari, E ^a   Moretti, T ^a   Bernardini, G ^a   Favaroni, M R ^a   Strom, R ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

Autoimmunity; Laboratory parameters; Natural killer cells; Systemic lupus erythematosus; T cells

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNITY; CELL SUBPOPULATION; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DISEASE ACTIVITY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 0034122091     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120300678828460     Document Type: Article

References (30)

1. Trincheri G. Biology of natural killer cells. Adv Immunol 1989; 47: 187-376.
2. Takeda K, Dennert G. The development of autoimmunity in C57B1/6 lpr mice correlates with the disappearance of natural killer type-1 positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms. J Exp Med 1993; 177: 155-164.
3. Wilder JA, Koh CY, Yuan D. The role of NK cells during in vivo antigen-specific antibody responses. J Immunol 1996; 156: 146.
4. Lanier LL, Philips H. Evidence for three types of human cytotoxic lymphocytes. Immunol Today 1986; 7: 132-134.
5. Brenner MB, McLean J, Dialynas DP et al. Identification of a putative second T-cell receptor. Nature 1986; 322: 145-149.
6. Morita CT, Verma S, Aparicio P, Martinez-AC, Spits H, Brenner MB. Functionally distinct subsets of human γ/δ T cells. Eur J Immunol 1991; 21: 2999-3007.
7. Peng SL, Madaio MP, Hayday AC, Craft J. Propagation and regulation of systemic autoimmunity by γ/δ T cells. J Immunol 1996; 157: 5689-5698.
8. Ferrini S, Zarcone D, Viale M et al. Morphologic and functional characterization of human peripheral blood cells expressing the γ/δ T cell receptor. Eur J Immunol 1989; 19: 1183-1188.
9. Kiode J, Rivas A, Engleman EG. Natural killer (NK) cytotoxic activity of allospecific T cell receptor-γ/δ + T cell clones: distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity. J Immunol 1989; 142: 4161-4168.
10. Porcelli S, Brenner MB, Band H. Biology of the human γ/δ T-cell receptor. Immunol Rev 1991; 120: 137-183.
11. Giacomelli R, Matucci-Cerinic M, Cipriani P et al. Circulating Vδ1 + T cells are activated and accumulate in the skin of systemic sclerosis patients. Arthritis Rheum 1998; 41: 327-334.
12. Rivera J, Horowitz DA. Regulatory effects of activated CD3 + double negative (CD4 - CDS - ) T cells and a novel triple negative (CD3 - CD4 - CD8 - ) subset on CD4 + helper cell activity. Arthritis Rheum 1991; 34: S164.
13. Di Fabrizio L, Kimura Y, Ware R, Ragozinski L, Chess L. Specific triggering of γ/δ T cells by K562 activates the γ/δ T cell receptor and may regulate natural killer-like function. J Immunol 1991; 146: 2495.
14. Van Vlasselaer P, Gascan H, De Waal Malefyt R, De Vries JE. IL-2 and a contact-mediated signal provided by TCRαβ+ or TCRγδ + CD4 + T cells induce polyclonal Ig production by committed human B cells: enhancement by IL-5, specific inhibition of IgA synthesis by IL-4. J Immunol 1992; 148: 1674.
15. Herberman RB, Whiteside TL. The role of natural killer cells in human disease. Clin Immunol Immunopathol 1989; 53: 1-23.
16. Struyf NJ, Snoeck HW, Bridts CH, De Clerck LS, Stevens WJ. Natural killer cell activity in Sjogren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin 2 and correlation with immune complexes. Ann Rheum Dis 1990; 49: 690-693.
17. Erkeller-Yuksel F, Hulstaart F, Hannet I, Isenberg D, Lydyard P. Lymphocyte subsets in a large cohort of patients with systemic lupus erythematosus. Lupus 1993; 2: 227-231.
18. Erkeller-Yuksel F, Lydyard P, Isenberg DA. Lack of NK cells in lupus patients with renal involvement. Lupus 1997; 6: 708-712.
19. Liossis SNC, Vassilopoulos D, Kovacs B, Tsokos GC. Immune cell biochemical abnormalities in systemic lupus erythematosus. Clin Exp Rheum 1997; 15: 677-684.
20. Lunardi C, Marguerie C, Bowness P, Walport MJ, So AK. Reduction in Tγδ cell numbers and alteration in subset distribution in systemic lupus erythematosus. Clin Exp Immunol 1991; 86: 203-206.
21. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
22. Vitali C, Bencivelli W, Isenberg DA et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Group Disease Activity in SLE. Clin Exp Rheumatol 1992; 10: 541-547.
23. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Committee on Prognosis Studies in SLE: derivatives of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-640.
24. Reichert T, DeBruyere M, Deneys V et al. Lymphocyte subset reference ranges in adult Caucasians. Clin Immunol Immunopathol 1991; 60: 190-208.
25. Bakke AC, Kirkland PA, Kitridou RC, Quismorio FP, Rea T, Ehresmann GR, Horwitz DA. T lymphocyte subsets in systemic lupus erythematosus. Correlation with corticosteroid therapy and disease activity. Arthritis Rheum 1983; 26: 745-750.
26. Stohl W. Impaired polyclonal T cell cytolytic activity: a possible risk factor for systemic lupus erythematosus. Arthritis Rheum 1995; 38: 506-516.
27. Dastot H, Schmid M, Gontier C et al. Correlation between T cell receptor γ/δ isotypic forms and cytotoxic activity with human T cell clones and lines. Cell Immunol 1990; 125: 315-325.
28. Cron RQ, Gajewski TF, Sharrow SW et al. Phenotypic and functiona analysis of murine CD3 +, CD4 -, CD8 -, TCR-γ/δ-expressing peripheral T cells. J Immunol 1989; 142: 2754-2762.
29. Harada M, Lin T, Kurosawa S et al. Natural killer cells inhibit the development of autoantibody production in (C57BL/6 X DBA/2) F1 hybrid mice injection with DBA/2 spleen cells. Cell Immunol 1995; 161: 42-49.
30. Horwitz DA, Stohl W, Gray JD. T lymphocytes, natural killer cells, cytokines, and immune regulation. In: Wallace DJ, Hahn BH (eds) Dubois' Lupus Erythematosus. Williams and Wilkins, USA. 1997; 155-194.